CLINICAL_TRIALS
trial_result
· 2017-02-10
Clinical Trial Update: Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A [Phase 1]
Summary
Phase 1 pharmacokinetic study of turoctocog alfa in subjects with Hemophilia A has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A | Phase 1 | Status: COMPLETED